Tissue microarray cytometry reveals positive impact of homeodomain interacting protein kinase 2 in colon cancer survival irrespective of p53 function

American Journal of Pathology

Volumn 178, Issue 5, 2011, Pages 1986-1998

  Soubeyran, Isabelle ^a   Mahouche, Isabelle ^a   Grigoletto, Aude ^a   Leste Lasserre, Thierry ^b   Drutel, Guillaume ^b   Rey, Christophe ^a   Pedeboscq, Stephane ^a   Blanchard, France ^c   Brouste, Veronique ^a   Sabourin, Jean Christophe ^c   Bécouarn, Yves ^a   Reiffers, Josy ^a   Ichas, François ^a,d   De Giorgi, Francesca ^a,d  

^a INSERM   (France)

^b INSTITUT FRANÇOIS MAGENDIE   (France)

^c UNIVERSITÉ DE ROUEN   (France)

^d FLUOFARMA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HOMEODOMAIN INTERACTING PROTEIN KINASE 2; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER SURVIVAL; COLORECTAL CARCINOMA; CYTOMETRY; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETROSPECTIVE STUDY; TISSUE MICROARRAY;

EID: 79959242487     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.01.021     Document Type: Article

References (28)

1. Vousden KH, Prives C: Blinded by the light: the growing complexity of p53. Cell 2009, 137:413-431
2. Iacopetta B: TP53 mutation in colorectal cancer. Hum Mutat 2003, 21:271-276
3. Iacopetta B, Russo A, Bazan V, Dardanoni G, Gebbia N, Soussi T, Kerr D, Elsaleh H, Soong R, Kandioler D, Janschek E, Kappel S, Lung M, Leung CS, Ko JM, Yuen S, Ho J, Leung SY, Crapez E, Duffour J, Ychou M, Leahy DT, O'Donoghue DP, Agnese V, Cascio S, Di Fede G, Chieco-Bianchi L, Bertorelle R, Belluco C, Giaretti W, Castagnola P, Ricevuto E, Ficorella C, Bosari S, Arizzi CD, Miyaki M, Onda M, Kampman E, Diergaarde B, Royds J, Lothe RA, Diep CB, Meling GI, Ostrowski J, Trzeciak L, Guzinska-Ustymowicz K, Zalewski B, CapellÁ GM, Moreno V, Peinado MA, Lönnroth C, Lundholm K, Sun XF, Jansson A, Bouzourene H, Hsieh LL, Tang R, Smith DR, Allen-Mersh TG, Khan ZA, Shorthouse AJ, Silverman ML, Kato S, Ishioka C; TP53-CRC Collaborative Group: Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. Ann Oncol 2006, 17: 842-847
4. Russo A, Bazan V, Iacopetta B, Kerr D, Soussi T, Gebbia N: The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment. J Clin Oncol 2005, 23: 7518-7528 (Pubitemid 46291815)
5. Kruse JP, Gu W: Modes of p53 regulation. Cell 2009, 137:609-622
6. Kim YH, Choi CY, Lee SJ, Conti MA, Kim Y: Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors. J Biol Chem 1998, 273:25875-25879 (Pubitemid 28475817)
7. D'Orazi G, Cecchinelli B, Bruno T, Manni I, Higashimoto Y, Saito S, Gostissa M, Coen S, Marchetti A, Del Sal G, Piaggio G, Fanciulli M, Appella E, Soddu S: Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat Cell Biol 2002, 4:11-19
8. Dauth I, Kruger J, Hofmann TG: Homeodomain-interacting protein kinase 2 is the ionizing radiation-activated p53 serine 46 kinase and is regulated by ATM. Cancer Res 2007, 67:2274-2279 (Pubitemid 46424247)
9. Hofmann TG, Möller A, Sirma H, Zentgraf H, Taya Y, Dröge W, Will H, Schmitz ML: Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat Cell Biol 2002, 4:1-10 (Pubitemid 34071974)
10. Mayo LD, Seo YR, Jackson MW, Smith ML, Rivera Guzman J, Korgaonkar CK, Donner DB: Phosphorylation of human p53 at serine 46 determines promoter selection and whether apoptosis is attenuated or amplified. J Biol Chem 2005, 280:25953-25959 (Pubitemid 41022185)
11. Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T, Nishimori H, Tamai K, Tokino T, Nakamura Y, Taya Y: p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 2000, 102:849-862
12. Rinaldo C, Prodosmo A, Mancini F, Iacovelli S, Sacchi A, Moretti F, Soddu S: MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis. Mol Cell 2007, 25:739-750 (Pubitemid 46341925)
13. Guo A, Salomoni P, Luo J, Shih A, Zhong S, Gu W, Pandolfi PP: The function of PML in p53-dependent apoptosis. Nat Cell Biol 2000, 2:730-736
14. Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, Saito S, Higashimoto Y, Appella E, Minucci S, Pandolfi PP, Pelicci PG: PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 2000, 406:207-210
15. Di Stefano V, Blandino G, Sacchi A, Soddu S, D'Orazi G: HIPK2 neutralizes MDM2 inhibition rescuing p53 transcriptional activity and apoptotic function. Oncogene 2004, 23:5185-5192 (Pubitemid 38980351)
16. Di Stefano V, Mattiussi M, Sacchi A, D'Orazi G: HIPK2 inhibits both MDM2 gene and protein by, respectively, p53-dependent and independent regulations. FEBS Lett 2005, 579:5473-5480 (Pubitemid 41455617)
17. Nardinocchi L, Puca R, Sacchi A, D'Orazi G: HIPK2 knock-down compromises tumor cell efficiency to repair damaged DNA. Biochem Biophys Res Commun 2007, 361:249-255 (Pubitemid 47102293)
18. Puca R, Nardinocchi L, Gal H, Rechavi G, Amariglio N, Domany E, Notterman DA, Scarsella M, Leonetti C, Sacchi A, Blandino G, Givol D, D'Orazi G: Reversible dysfunction of wild-type p53 following homeodomain-interacting protein kinase-2 knockdown. Cancer Res 2008, 68:3707-3714
19. Hofmann TG, Stollberg N, Schmitz ML, Will H: HIPK2 regulates transforming growth factor-beta-induced c-Jun NH(2)-terminal kinase activation and apoptosis in human hepatoma cells. Cancer Res 2003, 63:8271-8277
20. Wang SY, Iordanov M, Zhang Q: c-Jun NH2-terminal kinase promotes apoptosis by down-regulating the transcriptional co-repressor CtBP. J Biol Chem 2006, 281:34810-34815 (Pubitemid 46036520)
21. Zhang Q, Nottke A, Goodman RH: Homeodomain-interacting protein kinase-2 mediates CtBP phosphorylation and degradation in UV-triggered apoptosis. Proc Natl Acad Sci U S A 2005, 102:2802-2807 (Pubitemid 40299873)
22. Sombroek D, Hofmann TG: How cells switch HIPK2 on and off. Cell Death Differ 2009, 16:187-194
23. Calzado MA, Renner F, Roscic A, Schmitz ML: HIPK2: a versatile switchboard regulating the transcription machinery and cell death. Cell Cycle 2007, 6:139-143 (Pubitemid 46232491)
24. Gresko E, Roscic A, Ritterhoff S, Vichalkovski A, del Sal G, Schmitz ML: Autoregulatory control of the p53 response by caspase-mediated processing of HIPK2. EMBO J 2006, 25:1883-1894
25. Winter M, Sombroek D, Dauth I, Moehlenbrink J, Scheuermann K, Crone J, Hofmann TG: Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR. Nat Cell Biol 2008, 10:812-824 (Pubitemid 351927710)
26. Flaman JM, Frebourg T, Moreau V, Charbonnier F, Martin C, Chappuis P, Sappino AP, Limacher JM, Bron L, Benhattar J, Tada M, van Meir EG, Estreicher A, Iggo RD: Simple p53 functional assay for screening cell lines, blood, and tumors. Proc Natl Acad Sci U S A 1995, 92:3963-3967
27. Westra JL, Schaapveld M, Hollema H, de Boer JP, Kraak MM, de Jong D, ter Elst A, Mulder NH, Buys CH, Hofstra RM, Plukker JT: Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients. J Clin Oncol 2005, 23:5635-5643
28. Tellez CS, Davis DW, Prieto VG, Gershenwald JE, Johnson MM, McCarty MF, Bar Eli M: Quantitative analysis of melanocytic tissue array reveals inverse correlation between activator protein-2alpha and protease-activated receptor-1 expression during melanoma progression. J Invest Dermatol 2007, 127:387-393 (Pubitemid 46106918)